Guardant Health to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Guardant Health, a leading precision oncology company, will participate virtually in several key investor conferences in February and March 2022. The conferences include:

• 11th Annual SVB Leerink Global Healthcare Conference on February 16 at 9:00 a.m. PT.
• Citi 2022 Healthcare Conference on February 24 at 11:45 a.m. PT.
• Cowen 42nd Annual Health Care Conference on March 8 at 10:30 a.m. PT.

Live and archived webcasts will be available on the company's website. Guardant Health aims to enhance cancer care through its innovative tests and analytics.

REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will be participating virtually in the following investor conferences.

• 11^th Annual SVB Leerink Global Healthcare Conference
  Fireside Chat on Wednesday, February 16 ^th at 9:00 a.m. Pacific Time / 12:00 p.m. Eastern Time

• Citi 2022 Healthcare Conference
  Fireside Chat on Thursday, February 24 ^th at 11:45 a.m. Pacific Time / 2:45 p.m. Eastern Time

• Cowen 42^nd Annual Health Care Conference
  Fireside Chat on Tuesday, March 8 ^th at 10:30 a.m. Pacific Time / 1:30 p.m. Eastern Time

Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.guardanthealth.com.

About Guardant Health

Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has commercially launched Guardant360®, Guardant360 CDx, Guardant360 TissueNext™, Guardant360 Response™, and GuardantOMNI® tests for advanced stage cancer patients, and Guardant Reveal™ for early-stage cancer patients. These tests fuel development of its screening program, which aims to address the needs of asymptomatic individuals eligible for cancer screening.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220207005083/en/

Investor Contact:

Carrie Mendivil

investors@guardanthealth.com

Media Contact:

Michele Rest

press@guardanthealth.com

Source: Guardant Health, Inc.

FAQ

What conferences will Guardant Health participate in February 2022?

Guardant Health will participate in the 11th Annual SVB Leerink Global Healthcare Conference on February 16, and the Citi 2022 Healthcare Conference on February 24.

What is the schedule for Guardant Health's investor conferences?

Guardant Health's investor conferences are scheduled for February 16 at 9:00 a.m. PT, February 24 at 11:45 a.m. PT, and March 8 at 10:30 a.m. PT.

Where can I watch the Guardant Health investor conference webcasts?

You can access live and archived webcasts of Guardant Health's investor conferences on their website under the 'Investors' section.

What is the significance of Guardant Health's participation in these conferences?

Guardant Health's participation in these conferences highlights their commitment to precision oncology and provides insights into their advancements in cancer care.

What is the stock symbol for Guardant Health?

The stock symbol for Guardant Health is GH.